These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 28873000)

  • 21. Cross-reactivity between Candida albicans and oral squamous cell carcinoma revealed by monoclonal antibody C7.
    Rodríguez MJ; Schneider J; Moragues MD; Martínez-Conde R; Pontón J; Aguirre JM
    Anticancer Res; 2007; 27(5B):3639-43. PubMed ID: 17972529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced podocalyxin expression alters the structure of podocyte basal surface.
    Economou CG; Kitsiou PV; Tzinia AK; Panagopoulou E; Marinos E; Kershaw DB; Kerjaschki D; Tsilibary EC
    J Cell Sci; 2004 Jul; 117(Pt 15):3281-94. PubMed ID: 15226400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of kallikrein-related peptidase-4 in oral cancer.
    Papagerakis P; Pannone G; Zheng LI; Athanassiou-Papaefthymiou M; Yamakoshi Y; McGuff HS; Shkeir O; Ghirtis K; Papagerakis S
    Anticancer Res; 2015 Apr; 35(4):1861-6. PubMed ID: 25862839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cell surface mucin podocalyxin regulates collective breast tumor budding.
    Graves ML; Cipollone JA; Austin P; Bell EM; Nielsen JS; Gilks CB; McNagny KM; Roskelley CD
    Breast Cancer Res; 2016 Jan; 18(1):11. PubMed ID: 26796961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FBXW7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: A single-center retrospective study.
    Arita H; Nagata M; Yoshida R; Matsuoka Y; Hirosue A; Kawahara K; Sakata J; Nakashima H; Kojima T; Toya R; Murakami R; Hiraki A; Shinohara M; Nakayama H
    Tumour Biol; 2017 Oct; 39(10):1010428317731771. PubMed ID: 29072128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD44v3+/CD24- cells possess cancer stem cell-like properties in human oral squamous cell carcinoma.
    Todoroki K; Ogasawara S; Akiba J; Nakayama M; Naito Y; Seki N; Kusukawa J; Yano H
    Int J Oncol; 2016 Jan; 48(1):99-109. PubMed ID: 26647656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning of hamster osteopontin and expression distribution in normal tissues and experimentally induced oral squamous-cell carcinoma.
    Jin H; Valverde P; Chen J
    Arch Oral Biol; 2006 Mar; 51(3):236-45. PubMed ID: 16095557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Podocalyxin expression in malignant astrocytic tumors.
    Hayatsu N; Kaneko MK; Mishima K; Nishikawa R; Matsutani M; Price JE; Kato Y
    Biochem Biophys Res Commun; 2008 Sep; 374(2):394-8. PubMed ID: 18639524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GLI-mediated Keratin 17 expression promotes tumor cell growth through the anti-apoptotic function in oral squamous cell carcinomas.
    Mikami Y; Fujii S; Nagata K; Wada H; Hasegawa K; Abe M; Yoshimoto RU; Kawano S; Nakamura S; Kiyoshima T
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1381-1393. PubMed ID: 28342001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression changes in initiation and progression of oral squamous cell carcinomas revealed by laser microdissection and oligonucleotide microarray analysis.
    Sumino J; Uzawa N; Okada N; Miyaguchi K; Mogushi K; Takahashi K; Sato H; Michikawa C; Nakata Y; Tanaka H; Amagasa T
    Int J Cancer; 2013 Feb; 132(3):540-8. PubMed ID: 22740306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma.
    Schopperle WM; DeWolf WC
    Stem Cells; 2007 Mar; 25(3):723-30. PubMed ID: 17124010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of monoclonal antibodies with specificity to oral squamous cell carcinoma.
    Fantozzi RD
    Laryngoscope; 1991 Oct; 101(10):1076-80. PubMed ID: 1921634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
    Shintani S; Yoshihama Y; Emilio AR; Matsumura T
    Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production and characterization of murine monoclonal antibodies against human podocalyxin.
    Rodríguez RB; Butta N; Larrucea S; Alonso S; Parrilla R
    Tissue Antigens; 2006 Nov; 68(5):407-17. PubMed ID: 17092254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma.
    Bhawal UK; Ozaki Y; Nishimura M; Sugiyama M; Sasahira T; Nomura Y; Sato F; Fujimoto K; Sasaki N; Ikeda MA; Tsuji K; Kuniyasu H; Kato Y
    Oncology; 2005; 69(3):246-55. PubMed ID: 16127291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Keratin 19 downregulation by oral squamous cell carcinoma lines increases invasive potential.
    Crowe DL; Milo GE; Shuler CF
    J Dent Res; 1999 Jun; 78(6):1256-63. PubMed ID: 10371250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human embryonal carcinoma tumor antigen, Gp200/GCTM-2, is podocalyxin.
    Schopperle WM; Kershaw DB; DeWolf WC
    Biochem Biophys Res Commun; 2003 Jan; 300(2):285-90. PubMed ID: 12504081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of p53 and HER-2/neu genes status and protein products in oral squamous cell carcinomas.
    Stoicănescu D; Andreescu N; Belengeanu A; Meszaros N; Cornianu M
    Rom J Morphol Embryol; 2013; 54(4):1107-13. PubMed ID: 24399009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the antibody immunotherapy by the anti-MUC1 monoclonal antibody to the oral squamous cell carcinoma in vitro.
    Shimizu M; Imai M
    Biol Pharm Bull; 2008 Dec; 31(12):2288-93. PubMed ID: 19043215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression.
    Somasiri A; Nielsen JS; Makretsov N; McCoy ML; Prentice L; Gilks CB; Chia SK; Gelmon KA; Kershaw DB; Huntsman DG; McNagny KM; Roskelley CD
    Cancer Res; 2004 Aug; 64(15):5068-73. PubMed ID: 15289306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.